Newsfeeds Archive - Spark Newswire

2 minute read

February 20, 8:55 AM

Gracell Biotechnologies Inc. (("Gracell" or the "Company", NASDAQ:GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for

AZN

2 minute read

Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment

By Vandana Singh

January 23, 9:19 AM

In a significant development, the FDA is set to impose a classwide black box warning following its investigation into secondary T-cell cancers arising from the use of existing CAR-T therapies.

AZN

4 minute read

Small Cap

With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs

By The Bamboo Works

January 5, 11:26 AM

Key Takeaways: AstraZeneca will acquire Chinese cell therapy maker Gracell for up to $1.2 billion, representing an 86% premium to the company’s pre-announcement share price

AZN

2 minute read

Investor Sentiment Improves; Dow Jumps Over 150 Points

By Avi Kapoor

December 27, 4:28 AM

The CNN Money Fear and Greed index showed an increase in overall market sentiment, while the index remained in the "Extreme Greed" zone on Tuesday.

AZN

2 minute read

Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher

By Avi Kapoor

December 26, 3:43 PM

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.50% to 37,574.66 while the NASDAQ rose 0.50% to 15,068.50. The S&P 500 also rose, gaining, 0.45% to 4,776.17.

AZN

4 minute read

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Avi Kapoor

December 26, 2:48 PM

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday.

AAOI

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

December 26, 1:31 PM

Gainers RayzeBio (NASDAQ:RYZB) stock moved upwards by 100.8% to $61.4 during Tuesday’s regular session. The market value of…

BACK

2 minute read

Crude Oil Rises Over 3%; US Home Prices Increase In October

By Avi Kapoor

December 26, 1:20 PM

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.34% to 37,511.87 while the NASDAQ rose 0.43% to 15,057.13. The S&P 500 also rose, gaining, 0.34% to 4,770.79.

ADEX

2 minute read